Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of tranilast for trigeminal neuralgia
jRCTs061230013Phase 2Completed
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tranilast in trigeminal neuralgia (TN). Primary endpoint: Pain intensity (VAS). Started Oct 2023; status: completed.
02
Drugs
tranilast
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on jRCTs061230013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061230013.